FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions

While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to “circumvent safeguards.”

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top